Bendazac L-lysine

CAS : 81919-14-4

Ref. 3D-GDA91914

Informations sur le produit

• Nom: Bendazac L-lysine
• Synonymes: 2,6-diammoniohexanoate [(1-benzyl-1H-indazol-3-yl)oxy]acetate, <span class="text-smallcaps">L</span>-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1), <span class="text-smallcaps">L</span>-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate], Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. with <span class="text-smallcaps">L</span>-lysine (1:1), Af 1934, Bendaline, Bendazac <span class="text-smallcaps">L</span>-lysine salt, Bendazac lysine, Bendazac lysine salt, Bendazaclysine, L-Lysine-(1-benzyl-1H-indazol-3-yloxy)acetic acid

Description

Bendazac L-lysine is a coumarin derivative that is used in pharmaceutical preparations for the treatment of diabetic neuropathy. It has been shown to increase the levels of growth factors, such as insulin-like growth factor-1 and vascular endothelial growth factor, in diabetic patients. Bendazac L-lysine can be prepared by high performance liquid chromatography (HPLC) using preparative reverse phase HPLC. The fluorescence spectrometry of bendazac L-lysine was measured at 230 nm with excitation at 220 nm and emission at 255 nm. Bendazac L-lysine has also been shown to have an absorption enhancer effect on lysine, a necessary amino acid for collagen synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 428.48 g/mol
• Formule: C₂₂H₂₈N₄O₅
• Degré de pureté: Min. 95%